Top 50 Medical VC Funds & Investors in Germany (July 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
22 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $1.1M–$33M |
|
Bayern Kapital
VC Fund
|
17 | Germany, United States, Finland | Seed, Series A | Software, Health Care, Information Technology | $1.1M–$32M |
|
KfW
VC Fund
|
11 | Germany, India, United Kingdom | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
Calm/Storm VC
VC Fund
|
9 | United Kingdom, Germany, Austria | Seed, Pre-Seed, Series A | Health Care, Wellness, Software | $538k–$18M |
|
BioMedPartners
VC Fund
|
8 | Switzerland, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.9M–$83M |
|
DvH Ventures
VC Fund
|
8 | Germany, Austria, United Kingdom | Seed, Series A | Health Care, Software, Financial Services | $1.2M–$31M |
|
NRW.BANK
VC Fund
|
8 | Germany, United States, France | Seed, Series A, Series B | Information Technology, Software, Biotechnology | $219k–$71M |
|
MIG Capital
VC Fund
|
7 | Germany, France, Austria | Series A, Series B | Biotechnology, Health Care, Therapeutics | $1.6M–$54M |
|
Atlantic
VC Fund
|
6 | Germany, Switzerland, United States | Seed, Pre-Seed, Series A | Software, Health Care, Information Technology | $878k–$30M |
|
Brandenburg Kapital
VC Fund
|
6 | Germany, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $823k–$13M |
|
bm-t beteiligungsmanagement thuringen
VC Fund
|
6 | Germany, United States | Seed, Series A | Software, Health Care, Information Technology | $461k–$9.4M |
|
b2venture
VC Fund
|
6 | Germany, Switzerland, United Kingdom | Series A, Seed, Series B | Software, Health Care, Information Technology | $1.3M–$52M |
|
TGFS - Technologiegründerfonds Sachsen
VC Fund
|
6 | Germany, United States | Seed, Series A | Software, Information Technology, Manufacturing | $932k–$15M |
|
Wellington Partners
VC Fund
|
6 | Germany, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $3.1M–$55M |
|
Picus Capital
VC Fund
|
5 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Financial Services, Software, FinTech | $500k–$33M |
|
Possible Ventures
VC Fund
|
5 | Germany, Australia, United States | Seed, Pre-Seed, Series A | Software, Biotechnology, Information Technology | $549k–$47M |
|
Rheingau Founders
VC Fund
|
5 | Germany, United States, Poland | Seed, Series A, Pre-Seed | Software, E-Commerce, Internet | $110k–$14M |
|
HV Capital
VC Fund
|
5 | Germany, United Kingdom, United States | Series A, Seed, Series B | E-Commerce, Software, Internet | $1.6M–$80M |
|
Heal Capital
VC Fund
|
5 | Germany, United Kingdom, France | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Machine Learning | $1M–$33M |
|
IBB Ventures
VC Fund
|
5 | Germany, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $1M–$10M |
|
seed + speed Ventures
VC Fund
|
5 | Germany, Austria, Switzerland | Seed, Series A, Pre-Seed | Software, SaaS, Artificial Intelligence | $603k–$20M |
|
IFB Innovationsstarter
VC Fund
|
4 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $80k–$3M |
|
Vorwerk Ventures
VC Fund
|
4 | Germany, United Kingdom, Denmark | Seed, Series A, Series B | E-Commerce, Health Care, Software | $3.3M–$88M |
|
YZR Capital
VC Fund
|
4 | Germany, Poland, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical, Software | $742k–$52M |
|
KHAN Technology Transfer Fund
VC Fund
|
4 | Germany, Austria, Luxembourg | Seed, Series A, Venture - Series Unknown | Biotechnology, Medical, Biopharma | $259k–$10M |
|
Capacura
VC Fund
|
4 | Germany | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Recycling, Software | $661k–$2.9M |
|
European Investment Bank
VC Fund
|
4 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$658M |
|
BayBG Venture Capital
VC Fund
|
4 | Germany, Italy, United States | Series A, Series B | Software, Information Technology, Health Care | $428k–$21M |
|
EQT Life Sciences
VC Fund
|
4 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.9M–$165M |
|
Springboard Health Angels
VC Fund
|
4 | Germany, United States, Switzerland | Seed, Pre-Seed | Health Care, Medical, Software | $400k–$5.8M |
|
VI Partners
VC Fund
|
4 | Switzerland, Germany, United States | Series A, Series B, Seed | Health Care, Biotechnology, Software | $1.3M–$41M |
|
Speedinvest
VC Fund
|
4 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $549k–$33M |
|
SOSV
VC Fund
|
3 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Grazia Equity
VC Fund
|
3 | Germany, United States, Switzerland | Series A, Series B, Seed | Internet, E-Commerce, Biotechnology | $1.1M–$59M |
|
Bertelsmann Investments
VC Fund
|
3 | Germany, United States, Israel | Series A, Seed, Series B | Health Care, Medical, Artificial Intelligence | $3M–$46M |
|
Born2Grow
VC Fund
|
3 | Germany, Finland, United States | Seed, Series A, Series B | Software, Medical, Health Care | $1.1M–$6M |
|
LSP BioVentures
VC Fund
|
3 | United States, Germany, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $5.3M–$176M |
|
Forbion Capital Partners
VC Fund
|
3 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $16M–$176M |
|
Vesalius Biocapital Partners
VC Fund
|
3 | Belgium, Germany, France | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$100M |
|
Peppermint Venture Partners
VC Fund
|
3 | Germany, Belgium | Series A, Series B, Series C | Health Care, Medical, Biotechnology | $1.8M–$11M |
|
Winning Mindset Ventures
VC Fund
|
3 | Germany | Series A, Venture - Series Unknown | Medical, Health Care, Software | $13M–$13M |
|
Aescuvest
VC Fund
|
3 | Germany, Israel, Austria | Equity Crowdfunding, Seed, Pre-Seed | Health Care, Medical, Medical Device | $116k–$2.2M |
|
TechVision Fund
VC Fund
|
3 | Germany, Spain | Seed, Series A, Pre-Seed | Software, Health Care, Manufacturing | $2.7M–$28M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.8M–$50M |
|
UNIQA Ventures
VC Fund
|
3 | Austria, Germany, United Kingdom | Series A, Seed, Series B | FinTech, Insurance, Health Care | $439k–$125M |
|
Global Asset Fund
VC Fund
|
3 | Germany | Series A, Series B | Medical, Therapeutics, Biotechnology | $1M–$2.9M |
|
Project A Ventures
VC Fund
|
3 | Germany, United Kingdom, United States | Seed, Series A, Series B | Software, E-Commerce, Artificial Intelligence | $1.5M–$75M |
|
WestTech Ventures
VC Fund
|
3 | Germany, United States, France | Seed, Series A | Software, Internet, Information Technology | $1M–$12M |
|
Sparkasse Jena
VC Fund
|
3 | Germany, United States | Seed, Series A, Series C | Medical, Health Care, Shopping | |
|
Playground Global
VC Fund
|
3 | United States, Canada, Italy | Series A, Series B, Seed | Software, Robotics, Biotechnology | $2.2M–$150M |
| Access all 556 VC funds in Germany Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 586
- Round size: Seed $1.1M–$7.3M; Series A $3.5M–$33M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- Incirt — Incirt provides modulation bandwidth and highly energy-efficient data converter IP solutions, exploiting a novel, ground-breaking technology approach. They offer relevant applications including mmWave 5G, and 6G.
- Atriva Therapeutics — Therapies against viral infections. First-in-class host-targeting therapies to treat respiratory viral infections, including COVID-19 and influenza.
- OMEICOS Therapeutics — OMEICOS Therapeutics is developing a novel, first-in-class, small molecule utilizing a new Mode of Action. OMEICOS' novel therapeutic strategy is based upon the discovery of natural metabolites of omega-3 fatty acids that mediate a strong anti-arrhythmic effect. In contrast to all other anti-arrhythmic drugs, OMEICOS' substances activatean endogenous cardio-protective signaling pathway that not only stabilizes the heart rhythm but shall provide curative effects to the diseased organ by preventing its electrical and structural remodeling.
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States, Finland
Investor stats
- Total investments: 243
- Round size: Seed $1.1M–$5.9M; Series A $3.9M–$32M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $26M in 2010
Portfolio highlights
- CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
- Hema.to — Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
- ProGlove — ProGlove makes award-winning wearable wireless barcode scanners using BLE or RF technology for ergonomic and efficient hands-free workflows.
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, United Kingdom
Investor stats
- Total investments: 158
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Andercore — Andercore connects global suppliers and local buyers on one AI-driven platform, automating inventory selection, pricing, quotes, financing and global distribution at scale.
- AtlasEdge — AtlasEdge is an edge data center business with a mission to create the leading-edge platform, delivering seamless, localized and ultra-low latency digital infrastructure to customers. They provide a wide range of direct connectivity options to enable connectivity within their datacenters. All cabling is installed and managed by AtlasEdge and itsengineering team to ensure speed of installation and guaranteed quality and management.
- Quantum Systems — Our vision is to become the global leader in providing aerial data for decision making by the use of our drones.
Calm/Storm is an exclusive founder network and venture capital firm. We invest in purpose driven founders changing our life & health for the better. Headquartered in Vienna, Austria we invest in early-stage companies all over Europe and the US. We focus on the pre-seed and seed stages but also invest up to Series A.
Show more...Investment focus
- Industry: Health Care, Wellness, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 128
- Round size: Seed $1.1M–$6.5M; Pre-Seed $538k–$2.6M; Series A $7.6M–$18M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — raised $23M in 2020
Portfolio highlights
- Leaders21com — They offer our customers an exciting portfolio of practical training and services. Based on our many years of experience and our specially developed leadership approach. Flexibility and situational action are essential leadership qualities. That is why we also structure our cooperation with our customers in exactly the same way - flexible andadapted to individual requirements. Digital and analog.
- The Joy Club — The Joy Club offers online activities, events, classes, and experiences for elderly people to remove loneliness.
- Bea Fertility — Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Switzerland, Germany, France
Investor stats
- Total investments: 87
- Round size: Series A $5.5M–$31M; Series B $4.9M–$83M; Series C $5.8M–$48M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $113M in 2018
Portfolio highlights
- T-CURX — T-CURX is a biotechnology company focused on the development of personalized cancer immunotherapies. Utilizing a proprietary platform, T-CURX aims to advance the field of T cell therapies to address the challenges faced in treating various cancers. The company's innovative approach involves the creation of a new generation of T cells designedto improve patient outcomes. As a spin-out from the University Clinics Würzburg, Germany, T-CURX leverages the expertise of its co-founders, including Prof. Michael Hudecek, to pioneer in the area of CAR-T cell-based medicines. With a commitment to transforming cancer treatment, T-CURX is at the forefront of developing targeted therapies that offer hope for a more effective and personalized approach to cancer care.
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- ImmunOs Therapeutics — ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.
Investing early in Europe's most passionate founders.
Show more...Investment focus
- Industry: Health Care, Software, Financial Services
- Stage:Seed, Series A
- Geography: Germany, Austria, United Kingdom
Investor stats
- Total investments: 79
- Round size: Seed $1.2M–$7.7M; Series A $3.8M–$31M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- a2zebra — a2zebra is a zebra company that specializes in instructional technology for elementary school kids.
- Dermanostic — Dermanostic is an e-health app where patients receive a medical diagnosis and therapy recommendation for skin diseases.
- microsynetics GmbH — Developing hardware and software to help elderly people gaining more freedom and quality of life. Our first product is an emergency wristband which works together with an app, also connecting relatives via smartphone and phone integrated in the emergency wristband. The automated AI-based fall detection guarantees help even when the user - afteraccident - isn't capable anymore of activating the emergency call via integrated button.
NRW.BANK is the development bank for the state of North Rhine-Westphalia. It supports its owner – the state of North Rhine-Westphalia – in fulfilling its tasks, notably in the fields of structural, economic, social and housing policy. NRW.BANK pools the promotion and development programmes of the state of North Rhine-Westphalia, the FederalRepublic of Germany and the European Union and combines them with its own equity and debt products and advisory services. It offers the full range of financial products in three areas “Economy”, “Housing”, and “Infrastructure/Municipalities”. NRW.BANK operates in a competitively neutral manner as a partner of banks and savings banks.
Show more...Investment focus
- Industry: Information Technology, Software, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Germany, United States, France
Investor stats
- Total investments: 130
- Round size: Seed $219k–$7.7M; Series A $3.8M–$33M; Series B $3.8M–$71M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- OMMM — OMMM Operations Management Solutions is a software house that specializes in the digitization and automation of industrial planning.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
- Emergence Therapeutics — Emergence Therapeutics is a European biopharmaceutical company developing novel antibody-drug conjugates (ADC) to treat high-need cancers. Its lead program combines a highly specific antibody with optimized linker and payload technology to target Nectin-4 – an important target for a broad range of cancers which has been clinically validated as anADC target by enfortumab vedotin, now approved for the treatment of urothelial cancers by the US Food and Drug Administration. Emergence is also actively exploring opportunities to develop further first- or best-in-class ADCs driven by therapeutic need.
MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B
- Geography: Germany, France, Austria
Investor stats
- Total investments: 96
- Round size: Series A $2.2M–$40M; Series B $1.6M–$54M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — raised $70M in 2014
Portfolio highlights
- NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
- GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
- Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
Atlantic Labs supports and invests in mission-driven founders working on transformative technology ventures. <br><br>We partner with founders early, providing the capital, tools and network necessary to growing their companies and accompanying them on their entrepreneurial journey. We are currently active in areas including Digital Health, Future of Work, Machine Learning, Decentralized Networks, Mobility and Industrial Applications.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 212
- Round size: Seed $1.3M–$9.3M; Pre-Seed $878k–$5.3M; Series A $5.3M–$30M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Vyoma GmbH — Vyoma ensures satellite safety and real-time mapping of space objects with cameras on satellites paired with automation services.
- bonify — Bonify, a Berlin based FinTech-Start-up, enables customers to benefit from their credit scoring and financial data. The company gives customers free and easy access to their credit score and let them upload additional relevant data. Then, it offers tools and personalized recommendations to help optimize the customer’s financial situation.Foundedin 2015 by key executives of McKinsey and Zalando, bonify has received significant funding from internationally leading VCs and successful entrepreneurs.
- Again — SecondCircle makes carbon negative chemicals for a cleaner future. We are the first carbon negative chemical manufacturer that can scale to meet global demand. The best thing about it: we use carbon dioxide as a feedstock.
With a track record of over 20 years in venture capital and experience from more than 200 investments in numerous companies BFB Brandenburg Kapital GmbH (BFB) is the most active equity investor in Brandenburg. BFB invests in fast-growing technology-orientated companies throughout the whole life-cycle. Target sectors are ICT/Digital Economy,Life Science, MedTech, Proptech, Industrial Applications. BFB invests in companies based in or with facilities in Brandenburg. The current VC fund is financed by the European Regional Development Fund (ERDF) an Investitionsbank des Landes Brandenburg (ILB).
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 74
- Round size: Seed $823k–$6.1M; Series A $2.7M–$13M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Kupando — Kupando is a biopharmaceutical company that develops agonists to stimulates innate immunity.
- k2-mobility — Operators of heavy vehicle fleets are facing one of the most significant transformational challenges by switching to electric vehicles. The additional time for battery charging, the limited vehicle range as well as diligent planning of energy consumption need to be dynamically integrated and accounted for in their daily operations. K2Mobility's software PANION has a real-time connection to the transport and tour plans, to the vehicles, the chargers and the grid and is planning and optimizing charging for operational excellence, energy cost and Total Cost of Ownership.
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!bm|t supports innovative and growth-oriented companies in Thuringia with equity investments and venture capital.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 69
- Round size: Seed $461k–$7M; Series A $1.1M–$9.4M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Altavo — Altavo operates as a medical device startup. Altavo harness the power of machine learning and state-of-the-art sensor technology to improve the lives of people who have lost their voice.
- Peeriot — Peeriot is a B2B software high-tech startup with a breakthrough in IoT. Peeriot offers a low-code software suite that simplifies IoT data sharing by tenfold.
- Influnate — Influnate is a tool that allows you to send and receive money via social media. Influnate enables users in social networks to “send and receive money easily, securely and quickly”. This can be done with a comment, a link, or via the Influnate web application. “Redirects to paid websites are a thing of the past,” said the startup.
B2venture is a venture capital firm focused on early-stage investments in digital and industrial technology companies. B2venture invests EUR 100m+ per year in high-growth companies with ticket sizes from EUR 0.25m to 3.5m.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United Kingdom
Investor stats
- Total investments: 235
- Round size: Seed $1.3M–$9M; Series A $4M–$22M; Series B $8M–$52M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $135M in 2021
Portfolio highlights
- Kiin Bio — Drug discovery is a system problem, where every inefficiency amplifies the next. We have the solution.
- Kubermatic — Easily manage multiple Kubernetes clusters with the automation power of the Kubermatic platform. Scale your business with reliability.
- Calvin Risk — We help companies manage the risks of their AI algorithms!
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 154
- Round size: Seed $932k–$6M; Series A $1.9M–$15M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Cyber Insight — Cyber Insight - Measure, Manage, Mitigate Cyber Risks
- Fusion Bionic — Fusion Bionic is a solution provider for laser-based surface functionalization
- HandsOn Robotics —
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 196
- Round size: Series A $3.1M–$33M; Series B $7.7M–$55M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $222M in 2019
Portfolio highlights
- nyra health — myReha is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. myReha was founded in 2020 and was headquartered in Vienna, Austria.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
- Beren Therapeutics — Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient. The company was founded in 2020 and is based in Thousand Oaks, CA.
Picus Capital is an early-stage technology investment firm with a long-term investment philosophy. We work together with daring technology companies to build successful, global companies challenging the status quo and shaping tomorrow.
Show more...Investment focus
- Industry: Financial Services, Software, FinTech
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 357
- Round size: Seed $1.6M–$12M; Pre-Seed $500k–$4.4M; Series A $3.7M–$33M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $140M in 2024
Portfolio highlights
- Enpal — Kostenlose Planung von Solaranlagen. Gewinnbringende & schnelle Umsetzung von Photovoltaikanlagen inklusive professionelle Installation & Netzanschluss. Zum Festpreis!
- Everstores — Everstores makes use of your store data to speed up the sales process and give you a reasonable and transparent offer.
- Lightbase — Plan, align, and ship complex projects faster. Lightbase maps your architecture across services and hands agents the full context to make safe, coordinated changes.
Possible Ventures backs ambitious teams building frontier technology to positively impact society. We invest globally in the early stages, actively supporting founders via our collective of global entrepreneurs.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Australia, United States
Investor stats
- Total investments: 163
- Round size: Seed $1.6M–$10M; Pre-Seed $549k–$3.8M; Series A $9.7M–$47M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- EntryLevel — Learn in an affordable, peer-driven environment over 6 weeks with mentors from top companies across the world such as Atlassian, Wise and more.
- VSPARTICLE — VSPARTICLE develops nanoparticle generators for various applications such as sensors, batteries, catalysis, solar cells, healthcare, additive manufacturing, nano safety, and more. It also enables research and industry to generate new materials at the push of a button.They specialize in nanoparticle production and integration. The technologyspeeds up the developments of customers by producing the desired nanoparticles on location and integrate them directly in the final product. VSPARTICLE was founded in 2014 and is headquartered in Delft, The Netherlands.
- Omeda Studios — Developing Predecessor, a Third Person Multiplayer Online Battle Arena game for PC and console.
Rheingau Founders is a Berlin&Munich based Venture Capital firm active since 2011. Focusing on pre-seed to Series A investments in Europe, predominantly B2B in the fields of Marketplaces, Software as a Service, InsurTech, and eHealth. Rheingau targets start-ups that have the potential to sustainably disrupt existing processes and value chains.Besides the financial investment, we offer strategic support through the mentorship of our partners.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, Poland
Investor stats
- Total investments: 84
- Round size: Seed $110k–$6.3M; Pre-Seed $770k–$2.9M; Series A $2.4M–$14M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- MoleQlar — MoleQlar is a data and research-driven longevity company. It provides valuable information and offers consumers lab-tested nutritional supplements. The company focuses on functional medicine with optimized nutrition. Their product range includes Uthever NMN, Resveratrol, Betaine, Carnosine, and more. These products are aimed at lowering biologicalage and promoting health and longevity. MoleQlar also offers health tracking services. The company is certified in Germany and delivers its products EU-wide, including Switzerland.
- Qualifyze — Qualifyze (former ChemSquare) was founded out of the Technical University of Darmstadt in September 2017. Today, we are based in Frankfurt am Main, the heart of Germany’s pharmaceutical cluster, where the leading life science companies are based. Our team consists of 16 people with diverse backgrounds and areas of expertise in business,engineering, and technology as well as several strategic partners from the pharma, food and cosmetics industry.
- Akhetonics — Creating the first all-optical RISC Processor
We support exceptional founders in building market leading digital companies.
Show more...Investment focus
- Industry: E-Commerce, Software, Internet
- Stage:Series A, Seed, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 449
- Round size: Seed $1.6M–$12M; Series A $3.3M–$33M; Series B $7.5M–$80M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $834M in 2023
Portfolio highlights
- Exein — The firmware security software and middleware can be injected like a vaccine in the hardware and aims to defend it from inside, working directly into the firmware at a lower level.
- FINN — At finn our mission is to make mobility fun and sustainable: We help everyone who loves driving their own car but refuses the struggle, commitment and intransparent costs associated with car ownership. We achieve this by offering all-inclusive, immediately available, monthly car-subscriptions. Best thing, yet: While you drive we plant trees asevery journey is CO2 compensated.
- Isar Aerospace — Isar Aerospace develops and operates launch services for small and medium-sized satellites, supporting both dedicated and rideshare missions to orbit. Its core offering is the Spectrum launch vehicle, a two-stage rocket designed to deploy satellites and satellite constellations into low Earth orbit with flexible launch configurations. The companydesigns and manufactures its launch technology in-house, using automated production processes and a vertically integrated approach to vehicle development. In addition to launch services, Isar Aerospace works with commercial, institutional, and space industry customers seeking access to orbital transportation for satellite missions. The company focuses on expanding launch capacity and supporting the growing demand for satellite deployment and space-based infrastructure.
Heal Capital is a European venture capital fund backing mission-driven founders with capital and HealthTech-specific expertise, accelerating market access.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United Kingdom, France
Investor stats
- Total investments: 41
- Round size: Seed $1M–$9.5M; Pre-Seed $1.9M–$4M; Series A $9M–$33M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $102M in 2020
Portfolio highlights
- Apheris — Superior drug discovery models through federated data networks
- Avi Medical — Avi Medical is a digital health care company that provides telemedicine services. Its platform enables patients to book appointments, manage their health data, and chat with the practitioner. The company uses data-driven medicine to provide patients and healthcare workers with a streamlined, more modern experience.
- Entyre — Entyre's health care specialists consult home-staying patients and their relatives towards a better recovery.
Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 226
- Round size: Seed $1M–$5.5M; Series A $2.2M–$10M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $33M in 2022
Portfolio highlights
- dentolo — dentolo operates a dental insurance and ecosystem centered around customer needs.With its insurance solution, the company covers 100% in dental, instantly, with best value-for-money, market-leading customer satisfaction and an unmatched modern retail experience within its ecosystem. It addresses consumer demand with dental professionals in 25+regions, reaching 40m+ people nationwide. The company owns proprietary and scalable acquisition channels with the #1 dental guide in DACH and a deeply integrated ecosystem. It relentlessly focuses on customer experience and products that solve real-world pains to make dental care more transparent, affordable, and human.
- Famedly — Der Messenger der Gesundheitsbranche, der auch medizinische Arbeitsprozesse abbildet.
- dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Empowering visionary founders with pre-seed and seed funding for B2B software innovation. Partner with us to turn your aspirations into thriving businesses. Our expert support ensures your journey to success.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria, Switzerland
Investor stats
- Total investments: 80
- Round size: Seed $1.1M–$5.8M; Pre-Seed $603k–$3.9M; Series A $2.7M–$20M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Covalo — Covalo™ is disrupting how formulation-driven products are developed in the 3 trillion euro consumer goods industry so brands can reduce time to market by scouting ingredients and packaging, collaborating on projects, and purchasing -- all from one place. . Today it's one of the largest beauty ingredient search platforms that connects beautybrands with suppliers of ingredients, packaging, and services such as contract manufacturing, formulation, regulatory, compliance and testing. It also arms suppliers with the tools and real-time industry insights needed to effectively market products. Covalo launched in 2021 and is based in Switzerland.
- Finperks — Finperks provides a unified API platform that orchestrates prepaid products like gift cards, cashback, employee benefits, and crypto off-ramps for banks, fintechs, HR platforms, and crypto providers.
- SOUS — One easy-to-use tool to grow traffic, make online sales, seamlessly handle orders and drive retention. Built for food entrepreneurs, built with taste.
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 87
- Round size: Seed $365k–$3M; Grant $80k–$165k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
- Atrya — Atrya develops regulatory-compliant blockchain payments for international companies.
- DEALCIRCLE — DealCircle is a digital M&A solution and partner of hundreds of M&A advisors. We support in identifying buyers and addressing the market. This provides investors access to a comprehensive deal flow of relevant projects.
Backing early-stage startups that drive positive impact for people and planet
Show more...Investment focus
- Industry: E-Commerce, Health Care, Software
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, Denmark
Investor stats
- Total investments: 90
- Round size: Seed $3.3M–$12M; Series A $5.5M–$33M; Series B $10M–$88M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Averia — Averia is focused on geotechnical and environmental engineering. The company supports businesses in geotechnical engineering, hydrogeology, environmental technology.
- aiomics — Aiomics | Back to your calling.Across Europe, healthcare providers lose hours every day to fragmented documentation—handwritten notes, scanned PDFs, dictations, disconnected IT systems. The result: burnout, missed revenue, and patients feeling like they’re asked the same question three times.Aiomics changes this. Our AI-driven co-pilot capturesevery clinical detail—speech, handwriting, digital notes—and validates it in real time with a human-in-the-loop process. Interactive checklists surface missing information before the patient leaves, and audit-ready records flow straight back into existing systems. Built for GDPR, MDR, and the EU AI Act from day one, Aiomics makes documentation complete, compliant, and instantly usable.We don’t replace EHRs—we make them better. From admission and discharge reports to insurer forms, from therapist briefings to patient-friendly letters, Aiomics turns paperwork from a burden into an asset. For providers, that means fewer errors, faster reimbursements, and—most importantly—more time at the bedside.Our mission: to empower healthcare professionals by removing administrative burdens and elevating their decision-making with trusted AI guidance—so they can reconnect with why they chose this vocation in the first place.Who we are: Aiomics is co-founded by Dr. Sven Jungmann, a physician with frontline experience of administrative overload; Dr. Nikita Tarasov, a physicist and data scientist; and a lawyer who scaled one of Europe’s largest digital service companies. Together, we unite empathy, technical mastery, and regulatory expertise to build the trusted co-pilot for Europe’s healthcare providers.
- Pace Club — Pace Club is aimed at a growing target group of fitness enthusiasts who want to combine training, performance development and community.
We back ambitious HealthTech founders solving complex healthcare challenges. We provide capital, deep sector expertise, and hands-on support to build global champions.
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Poland, United Kingdom
Investor stats
- Total investments: 35
- Round size: Seed $2.6M–$5.5M; Pre-Seed $742k–$2.5M; Series A $10M–$52M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely still investing — raised $70M in 2022
Portfolio highlights
- Biorce — Biorce is an innovating HealthAI startup committed to transforming drug development through the use of artificial intelligence.
- dehaze — dehaze provides healthcare services by bringing medical AI models into clinical practice.
- Scripta Therapeutics — Biology decoded, disease undone - modulating transcription factors to restore health
KHAN Technology Transfer Fund operates as an investment firm.
Show more...Investment focus
- Industry: Biotechnology, Medical, Biopharma
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Germany, Austria, Luxembourg
Investor stats
- Total investments: 14
- Round size: Seed $259k–$10M; Series A $5.5M–$10M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
- iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
- KyDo Therapeutics — KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
Capacura is reinventing the venture capital market so that more start-ups get access to capital, knowledge, processes and solutions.
Show more...Investment focus
- Industry: Health Care, Recycling, Software
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 24
- Round size: Seed $661k–$2.9M; Pre-Seed $889k–$932k
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- odacova — Odacova is a SaaS company that provides individualized nutrition for corporate cafeterias and employee eating, utilizing web, Android, and iOS platforms.
- Foom — Foom is developing a modular technology for the local processing of organic waste.
- Everwave — Everwave is a social enterprise that focuses on preventing plastic pollution in rivers and oceans.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 481
- Round size: Post-IPO Debt $18M–$658M; Debt Financing $16M–$384M
- Lead/follow: 82% lead, 18% follow
Portfolio highlights
- RE:OCEAN — OUR MISSION IS TO FARM SALMON FOR THE BENEFIT OF HEALTH AND THE PLANET. WE'LL DO THIS BY BUILDING A LARGE SCALE FISH FARM IN THE middle OF SWEDEN. - WE'RE MAKING THE IMPOSSIBLE POSSIBLE - AN OCEAN ON LAND. RE:OCEAN IN BRIEF One in five salmons in Sweden 2026 will come from RE:OCEAN Fresh
- Ukrposhta — Ukrposhta sends and receives shipments from all over the world, as well as orders mail products sent to the most distant corners.
- Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
Innovative post-revenue startups with first customers trust us as highly reliable investors. We have been an active player in the venture capital market for over 25 years. Due to our evergreen approach, we offer institutional venture capital without the limitations of the usual fund structure. Predominantly we invest straight equity. Additionally,we can offer venture debt to mature startups close to break-even in order to avoid further dilution for founders. Being a private investment company we act as both lead investor or co-investor. We can also fulfill the private lead investor role for public investors like Bayern Kapital. Together we are increasing YOUR company's value.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Series A, Series B
- Geography: Germany, Italy, United States
Investor stats
- Total investments: 117
- Round size: Series A $428k–$6.6M; Series B $732k–$21M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- socialhub — Boost your social media success with SocialHub. Manage channels, schedule posts & get meaningful analytics. Try it out now!
- TalentRocket — Talent Rocket is a job search engine that enables its users to find jobs with a suitable work environment for them. Job seekers can select their preferred company culture, follow their favorite companies, and start career conversations with employers. Talent Rocket was founded in 2014 and is based in London, United Kingdom.
- Goodly Innovations — Goodly Innovations is the leading regulated industry-focused global Pharma 4.0 provider for extended reality shop floor guidance. From cleanrooms to secondary packaging areas, labs and more, Goodly can help improve Pharma and BioPharma clients efficiency, OEE, quality, training and more
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 182
- Round size: Series A $6.9M–$77M; Series B $12M–$110M; Series C $12M–$165M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $266M in 2023
Portfolio highlights
- LUMA Vision — OneProjects is an Irish-German cardiac imaging specialist.
- Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
- Rotation Medical — Rotation Medical Inc. manufactures and markets a collagen scaffold for rotational cuff disease in Minnesota. The company was formerly known as Denali Medical Inc. and changed its name to Rotation Medical Inc. in March 2010. Rotation Medical was founded in 2009 and headquartered in Plymouth, Minnesota.
Springboard Health Angels is a Berlin based Angel group to invest in early stage Digital Health startups
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 25
- Round size: Seed $932k–$5.8M; Pre-Seed $400k–$3.8M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Cellbyte — AI Agents for Pricing and Market Access Teams in the Pharmaceutical Industry.
- MedGlance AI — MedGlance AI is a pioneering HealthTech platform that transforms complex medical reports into intuitive, patient-friendly visual protocols. Utilizing advanced Generative AI and the NanoBanana 2 (gemini-3-flash) engine, we provide real-time anatomical visualizations to improve health literacy and patient outcomes. Our "Zero-Retention"protocol ensures total data privacy, making us a trusted partner for healthcare providers and individual patients alike. We are dedicated to ensuring Health Equity through accessible, visual-first medical communication
- Captain T Cell — Captain T Cell is a start-up project that develops T cell-based immunotherapies for cancer patients. The company identifies novel high-efficiency TCRs for the development of T cell immunotherapies. It focuses on CMC- and preclinical development for their lead candidates.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Vi Partners is a venture capital firm backing exceptional founders in healthcare and technology across Switzerland and Europe for over 25 years.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: Switzerland, Germany, United States
Investor stats
- Total investments: 111
- Round size: Seed $1.3M–$6.5M; Series A $3.7M–$24M; Series B $3.3M–$41M
- Lead/follow: 24% lead, 76% follow
- Last fund: May invest from a new fund soon — raised $117M in 2020
Portfolio highlights
- Equippo.com — Used construction equipment marketplace. Easy and safe. Only inspected machines. Worldwide delivery. Money Back Guaranteed. Buy Now, Pay Later!
- Nexthink — Discover what your employees need, see what they experience, know how they feel. Deliver IT that delights.
- Pay by Shopping (deal united) — paybyshopping.com Domain Name is available to Buy. Grab this great Domain from Daaz. Daaz has the lowest transaction fees in the industry. See our list of GTLD's,CCTLD's, New GTLD's,3N's, 6N's, 3L's, 6L's etc.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 552
- Round size: Seed $980k–$8M; Pre-Seed $549k–$4.1M; Series A $4M–$33M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $384M in 2022
Portfolio highlights
- Bikemap — Bikemap is the crowdsourced cycling map & navigation of the world. With the help of more than 2.3M users in 100 countries, Bikemap helps you find the best cycling route from A to B - every time. Users shared more than 4M cycling routes in all corners of the world - and within the Bikemap Premium subscription, tens of thousands get access tooffline, routing, map features.
- morgana — Morgana is reshaping the mortgage industry in Latam. With a 5x faster application process, in-depth market knowledge, privileged access to data, and superb team, we are a groundbreaking digital mortgage broker that will shortly be competing with banks.
- GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.
Show more...Investment focus
- Industry: Internet, E-Commerce, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 83
- Round size: Seed $1.1M–$8M; Series A $1.1M–$53M; Series B $4M–$59M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Q.ANT — Q.ANT develops photonic processors for AI and high-performance computing, utilizing light for information processing. The company also produces quantum sensors offering ultra-high magnetic field sensitivity in a compact form factor. These products aim to enable more intelligent and sustainable systems across various sectors like data centers,aerospace, and medical technology.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Patronus Group — Rethinking elderly healthcare
The Bertelsmann Investments division pools Bertelsmann's holdings in startups around the world.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, Israel
Investor stats
- Total investments: 23
- Round size: Seed $3M–$10M; Series A $10M–$20M; Series B $7.2M–$46M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- AppLike — AppLike develops apps for all mobile devices and provides mobile advertising, app recommendation, and innovative B2B solutions. The company was founded in 2015 and is headquartered in Hamburg, Germany.
- Take2 AI — We help sales leaders hit their quota by hiring high performing sales talent effortlessly - think 5x faster hires that stay 2x longer in the company.
- Andel — Andel platform strengthens pharmacy benefits by giving employers an affordable way to include GLP-1s and other brand name medications.
Born2Grow is a german venture fund focusing on early stage investments. They invest up to 500k€ in innovative business models. They are based in Heilbronn in Baden-Wuerttemberg. Born2Grow focus on investments lies within the MedTech, BioTech, FinTech area as well as some other online industries
Show more...Investment focus
- Industry: Software, Medical, Health Care
- Stage:Seed, Series A, Series B
- Geography: Germany, Finland, United States
Investor stats
- Total investments: 25
- Round size: Seed $1.1M–$6M; Series A $3M–$4.1M; Series B $1.1M–$3.3M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- Semorai — The SEMORAI Engineering AI Suite is your App Store for AI agents for reliable support in demanding mechanical engineering. Connect comprehensive engineering knowledge with your company know-how to accelerate your processes through AI to an unprecedented degree.
- SpinDrive — SpinDrive technology increases efficiency by at least 15%. We provide tailored active magnetic bearing (AMB) systems for OEM's with competitive price.
- Unchained Robotics — Unchained Robotics engages in the development of artificial intelligence-based control system for robots for electronics production.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 26
- Round size: Series A $5.3M–$176M; Series B $5.3M–$45M; Series C $8M–$100M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — raised $1.2B in 2022
Portfolio highlights
- Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
- Muna Therapeutics — Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
- HotSpot Therapeutics — HotSpot Therapeutics is a biotech startup that focuses on the development of allosteric therapies targeting regulatory sites on proteins. It develops a therapy platform to discover medicines and provide proper treatment to identify hotspots and locate pathway treatments for cancer, metabolic and rare diseases, leverages a database of hotspotstructures, harnessing the power of data science in its multidisciplinary approach to drug discovery, and helps patients to get treatment against several diseases.HotSpot Therapeutics was founded in 2017 and is headquartered in Boston, Massachusetts.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 200
- Round size: Series A $19M–$176M; Series B $16M–$155M; Series C $19M–$113M
- Lead/follow: 52% lead, 48% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
- Inflazome — Situs gacor premium Megawin188 paling banyak di minati oleh semua kalangan karena pecah selayar tanpa henti dan memiliki tampilan yang sangat memanjakan mata.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Vesalius Biocapital Partners invests in companies active in human health through venture capital funds raised since 2007. They have contributed to developing 20 companies since inception.With more than € 150 million under management in two funds. Vesalius Biocapital Partners plays the role of lead investor in the large majority of its financingrounds.Their companies are based in Europe allowing easy interaction with management.They invest in all stages of development and do not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Belgium, Germany, France
Investor stats
- Total investments: 61
- Round size: Series A $3.8M–$20M; Series B $4.4M–$27M; Series C $7M–$100M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Nutrium — Nutrium is the most up-to-date nutrition software for dietitians and nutritionists to manage their nutrition business with nutritional assessment, meal planning and progress tracking.
- ENYO Pharma — ENYO Pharma is a biopharmaceutical company incorporated in Jan, 2014, by four scientists of the Infectiology Research Center in Lyon, France, and three seeding partners (2 privates and 1 public).The company is based in the Infectiology Center of Lyonbiopôle in Lyon, France and maintains tight collaborations with the seminal Inserm team and theBSL4 laboratory Inserm-Jean Mérieux.ENYO Pharma has licensed several Inserm patents issued from the discoveries of the founding scientists and developed a unique platform for the identification of intracellular therapeutic targets and molecules.The company is developing treatments against the most important viruses and is thriving to become a global leader in anti-virals. Research and Development is currently focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company plans to conduct its molecules to Phase II clinical trials.
- Inflammatix — Inflammatix develops rapid point of care diagnostic tests by reading the immune system, and resolves major clinical health challenges.
PVP is a private venture capital firm based in Berlin, investing in early-stage healthcare companies across Europe with a focus on medical device, digital health, and platform technology companies. Peppermint VenturePartners was established in 2008 by Ingeborg Neumann, Dr. Joachim Rautter and Dr. Klaus Stöckemann.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Series B, Series C
- Geography: Germany, Belgium
Investor stats
- Total investments: 11
- Round size: Series A $1.8M–$3.8M; Series B $3.3M–$11M; Series C $6.9M–$7.7M
- Lead/follow: 36% lead, 64% follow
Portfolio highlights
- Miracor Medical — Miracor Medical is a medical device company developing disruptive solutions to treat severe heart diseases
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
- CEVEC Pharmaceuticals — Cell line development is an important step for robust bioproduction. Explore solutions for mAbs (CHO cell lines) and adeno-associated virus (AAV).
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Startseite von Winning Mindset Ventures
Show more...Investment focus
- Industry: Medical, Health Care, Software
- Stage:Series A, Venture - Series Unknown
- Geography: Germany
Investor stats
- Total investments: 3
- Round size: Series A $13M–$13M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- deepc — The Radiology AI Platform - Your effortless access to AI
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
Aescuvest’s mission is to facilitate and enable impactful investments into medical breakthrough innovation to disrupt and improve healthcare delivery models, products, and services. Aescuvest enables its investors to build their very individual portfolio of healthcare start-ups - according to their personal investment focus. A cooperation with EITHealth, and a growing network of partnerships across Europe, allow Aescuvest to source and evaluate the most promising healthcare investment opportunities, structure their financing rounds, and enable healthcare technology-driven investors, such as Business Angels, HNWIs, Family Offices, and Corporate Investors, to participate in healthcare investment opportunities by direct investments via SPV structures. The Investment Committee, composed of Aescuvest’s very own investment team and members of tthe Advisory Board of Aescuvest, both deeply rooted in the healthcare industry and with proven track records, have developed a strong and over the last years well tested, pre-screening and due diligence process, to identify and select healthcare start-ups. Aescuvest’’s Management (circle of General Partners) put their ‘skin’ into each investment by committing capital to each company prior introduction to the wider Aescuvest investor base. The combination of innovative ways for equity capital provision, with healthcare industry and investment expertise, provides the Aescuvest portfolio companies a unique platform to develop their business solution, accelerate their path towards commercialization, and lower market access barriers.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Equity Crowdfunding, Seed, Pre-Seed
- Geography: Germany, Israel, Austria
Investor stats
- Total investments: 26
- Round size: Seed $1.1M–$2.2M; Equity Crowdfunding $116k–$666k
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Caresyntax — Caresyntax is the only enterprise-scale surgical data solution you need to make surgery smarter, safer, and more profitable.
- piur imaging — PIUR´s tomographic ultrasound solutions turn any standard ultrasound system into a tomographic 3D imaging device, bridging the gap between 2D ultrasound and regular tomographic imaging modalities. With any conventional 2D ultrasound transducer, high-resolution tomographic images can be generated and stored as quantifiable volumes, enabling true AIpost-processing for efficient diagnostics. Current focus is on thyroid imaging where AI algorithms allow doctors a fast and objective analysis and classification of thyroid nodules.
VF-Funds for innovative and scalable start-ups from the Rhineland Area, Germany
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Spain
Investor stats
- Total investments: 33
- Round size: Seed $2.7M–$5.8M; Series A $5.4M–$28M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- Octonomy — octonomy: AI-as-a-Service mit der neuen Generation von KI-Agenten. 80 % Zeitersparnis, 24/7-Support in 30+ Sprachen, live in 20 Tagen.
- Wakeline — Wakeline is a deep-technology company developing continuously learning artificial intelligence systems for complex, changing environments.
- specter automation — Construction is the second least digitized sector in the world with 96% of all data being unused. Although detailed planning data is created upfront, a lack of suitable digital tools prevents its transfer to the construction site. SPECTER’s web-based construction management software uniquely incorporates the core components of constructionplanning, reducing the organizational burden on construction management and helping to meet project timelines and budgets.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 100
- Round size: Seed $1.8M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
UNIQA Ventures GmbH is the Venture Capital arm of UNIQA Insurance Group AG, a leading insurance carrier in Central & Eastern Europe and a pioneer in Corporate-backed Venture Capital in Austria and CEE. Based in Vienna, Austria, the firm is investing in outstanding business models driven by strong teams and a clear vision to shape the future ofkey industries. Investment areas are the future of Health, Mobility, Intelligent Home and FinTech/InsurTech as well as enabling technologies such as IoT, Blockchain, ML/AI.
Show more...Investment focus
- Industry: FinTech, Insurance, Health Care
- Stage:Series A, Seed, Series B
- Geography: Austria, Germany, United Kingdom
Investor stats
- Total investments: 39
- Round size: Seed $439k–$5.3M; Series A $5M–$13M; Series B $15M–$125M
- Lead/follow: 28% lead, 72% follow
Portfolio highlights
- ifeel — Ifeel is the emotional well-being platform for modern organizations. Ifeel is a unique workplace mental health platform for companies.
- GoUrban — goUrban offers mobility solutions for sharing operators and B2B fleet management. The way of transportation and mobility is changing rapidly. For operating smarter and using the opportunities of the sharing economy we provide you our fleet management OS.
- doctorly — doctorly is a digital medical infrastructure platform. We have a regulated, cloud powered, fully centralised, practice management platform for doctors, a fully connected health app for patients, and an integration platform for the wider industry to natively connect their tools & workflows directly with our doctors & patients.We are backedby amazing investors and driven by a desire to make positive and meaningful changes to the healthcare industry internationally.
Global Asset Fund is a private equity firm based in Germany that finances early and later stage venture investments. The fund enables the development of products and technologies that address a growing market of tomorrow.
Show more...Investment focus
- Industry: Medical, Therapeutics, Biotechnology
- Stage:Series A, Series B
- Geography: Germany
Investor stats
- Total investments: 8
- Round size: Series A $1M–$1.9M; Series B $1.6M–$2.9M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Siltectra — SILTECTRA is a high-tech company specializing in kerfless wafering and thinning, an innovative new technology for manufacturing wafers. Kerfless wafering by SILTECTRA is a platform technology which can be used in a wide variety of industries and for many different materials.
- Isarna Therapeutics — Isarna Therapeutics has an unmatched commitment to developing selective TGF-β inhibitors to effectively treat ophthalmic diseases. They are advancing a unique pipeline of novel oligonucleotides and combination modalities to transcend clinical response and improve patient outcomes.
Project A is an early-stage venture capital firm, combining financial and operational support for technology companies. In addition to $1bn in assets under management, Project A provides its portfolio companies with a wide range of operational support services. This includes more than 100 experts from key areas such as software engineering,business intelligence, marketing, and recruiting. The portfolio includes companies such as Trade Republic, sennder, KRY, Catawiki, WorldRemit, Spryker, and Voi.
Show more...Investment focus
- Industry: Software, E-Commerce, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 211
- Round size: Seed $1.5M–$10M; Series A $3.3M–$28M; Series B $11M–$75M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Linexa — Linexa develops cloud-based SaaS for decoding complex shop floor automation—parsing PLC, HMI, SCADA, and MES systems into a unified, searchable model.
- STARK — EUROPEAN DEFENCE SOVEREIGNTY
- Yoummday GmbH — yoummday‘s concept is based on the sharing economy‘s principles. Among an innovative software solution, the marketplace is matching clients and freelancing call center agents whom we call talents. Through the concept, the platform provides a solution to work as a freelancing talent globally. Moreover, the provided technology enables the possibilityfor the talents to work from home.Additionally, a customer‘s project can be implemented efficiently, individually, and flexibly. Next to a talent pool with above 20,000 registered talents, yoummday offers managed services for corporate clients, as well as a self-managing possibility. Both services are allowing the client to monitor the project in real-time based on personally defined KPI‘s. By giving talents up to 80% of the revenue, the motivation is increasing, because the freelancing talent is earning twice as much as a call center agent in their country they live in. The client only has to pay a yoummday provision as well as the talent remuneration which is leading to cost savings up to 40%. Furthermore, yoummday is responsible for training and quality checks which are regularly analyzed and individually modified.Founded in 2016 by Klaus Harisch, Pablo Harisch, and Lion Harisch, yoummday is constantly looking for motivated, self-empowering, curious, critical thinking and problem-solving employees who want to innovate the call center business. The Tech startup is constantly fast-growing and the vision is to create a brand that is an outstanding example as a leading shared economy company that is offering the main assets which are the talents an ecologically friendly way to work from home. Next to a fixed salary, employees are offered various tangible and intangible benefits that are individualized based on the needs of the employee. yoummday is a group-orientated company which is focusing on the employee as the core asset. The headquarter is based in the heart of Munich and a second branch is located in Sofia.
WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.
Show more...Investment focus
- Industry: Software, Internet, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States, France
Investor stats
- Total investments: 53
- Round size: Seed $1M–$12M; Series A $3M–$7M
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Notch — Boost your deal win rates and customer onboarding with Notch. Create tailored buyer experiences, structured action plans, and gain valuable insights. Try our demo today.
- Careloop — Berlin-based HR-tech and EduTech startup with a focus on the German healthcare industry.
- ClimateChoice — The software platform for decarbonizing companies and their supply chains.
Sparkasse Jena is a German savings bank offers a collection of financial products and services to private, retail, and corporate customers.
Show more...Investment focus
- Industry: Medical, Health Care, Shopping
- Stage:Seed, Series A, Series C
- Geography: Germany, United States
Investor stats
- Total investments: 7
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- NovaPump — The NovaPump GmbH is a cardiology company based in Jena/Germany devoloping cutting-edge therapeutical solutions in the field of non-invasive and percutaneous circulation support. The so called PERKAT (PERKutane KATheterpumpe) technique will be offered as pLVAD & pRVAD heart pumps for acute left or right heart patients within the nextyears. PERKAT works together with the current IABP technique (intra aortic balloon pump with about 200,000 cases p.a. internationally) and is the only-one catheter-based & self-expanding, pulsatile & ECG-triggered, cost-effective heart pump technique with a high pump performance. PERKAT is not available on the market so far. Articles in leading scientific journals and presentations at the top four international cardiology conferences in the last years show the medical need, the development status and the technological and medical advantages of PERKAT.
- PERCEPTEC — PERCEPTEC is an application-oriented think tank with the aim of accelerating the process of modernization and digitalization of the optometric and ophthalmological sector.
- DeepEn — DeepEn is a research transfer start-up from Leibniz Institute of Photonic Technologies. It focus on the development of solutions in the field of fibrephotonics, biophotonics and bioimaging.
Playground Global is an early-stage venture capital firm backing technical and scientific founders with deep engineering expertise, a collaborative environment, and a first-hand understanding of the intricacies of deep tech. Established in 2015 and headquartered in Palo Alto, CA, Playground’s mission is to transform ambitious ideas into impactfulbusinesses that benefit humanity and the planet. We invest in areas that span across next gen compute automation, energy transition and engineered biology. Playground has been an early – and frequently first investor – in companies that include PsiQuantum, Relativity Space, Ultima Genomics, MosaicML (acq. by Databricks), d-Matrix, and Strand Therapeutics.
Show more...Investment focus
- Industry: Software, Robotics, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, Canada, Italy
Investor stats
- Total investments: 137
- Round size: Seed $2.2M–$20M; Series A $7M–$35M; Series B $20M–$150M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $410M in 2023
Portfolio highlights
- Bodyport — Comprehensive care. One simple step.
- Saltbox — Saltbox makes the hardest parts of running an ecommerce business simple. Explore our logistics and warehouse solutions growing eCommerce companies
- Mangata Networks — Mangata Networks is transforming the way the world accesses information, through satellite and terrestrial network solutions.
Medical VC funding in Germany at a glance
Stats across 471 deals from 556 investors.
Access all 556 VC funds in Germany Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 556 VC funds investing in Germany Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!